Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Hydromorphone for Wound Healing
NCT00177060Phase 2Terminated
- Start
- Oct 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of hydromorphone in wound (2 arms). Primary endpoints: Healing rates and Microvessel density. Started Oct 2003; status: terminated.
02
Drugs
hydromorphone
03
Conditions
wound
Beyond the preview
Go deeper on NCT00177060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177060.